NeuroMetrix Preferred Stock Total Equity vs Other Liab Analysis

Stocks . USA . 
Stock . NeuroMetrix
NURO Stock  USD 3.90  0.13  3.23%   
NeuroMetrix financial indicator trend analysis is infinitely more than just investigating NeuroMetrix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeuroMetrix is a good investment. Please check the relationship between NeuroMetrix Preferred Stock Total Equity and its Other Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

Preferred Stock Total Equity vs Other Liab

Preferred Stock Total Equity vs Other Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeuroMetrix Preferred Stock Total Equity account and Other Liab. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between NeuroMetrix's Preferred Stock Total Equity and Other Liab is -0.05. Overlapping area represents the amount of variation of Preferred Stock Total Equity that can explain the historical movement of Other Liab in the same time period over historical financial statements of NeuroMetrix, assuming nothing else is changed. The correlation between historical values of NeuroMetrix's Preferred Stock Total Equity and Other Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Preferred Stock Total Equity of NeuroMetrix are associated (or correlated) with its Other Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Liab has no effect on the direction of Preferred Stock Total Equity i.e., NeuroMetrix's Preferred Stock Total Equity and Other Liab go up and down completely randomly.

Correlation Coefficient

-0.05
Relationship DirectionNegative 
Relationship StrengthInsignificant

Preferred Stock Total Equity

Other Liab

Most indicators from NeuroMetrix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuroMetrix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.As of the 11th of December 2024, Selling General Administrative is likely to drop to about 4.7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 2.5 M
 2021 2022 2023 2024 (projected)
Gross Profit5.9M5.8M3.9M3.8M
Total Revenue8.3M8.3M5.9M5.6M

NeuroMetrix fundamental ratios Correlations

Common Stock Shares Outstanding
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Preferred Stock Total Equity
Common Stock Shares Outstanding
0.27-0.16-0.27-0.120.29-0.260.290.22-0.19-0.47-0.270.21-0.05-0.230.240.28-0.440.05-0.210.1-0.260.43-0.230.25-0.18
Total Assets
0.27-0.32-0.59-0.420.7-0.15-0.08-0.03-0.37-0.45-0.170.38-0.34-0.30.120.98-0.240.08-0.320.15-0.340.53-0.380.69-0.3
Short Long Term Debt Total
-0.16-0.320.590.630.090.340.180.290.02-0.330.66-0.02-0.25-0.38-0.61-0.320.150.46-0.350.050.710.28-0.28-0.14-0.39
Other Current Liab
-0.27-0.590.590.92-0.10.140.050.390.02-0.010.75-0.03-0.19-0.24-0.65-0.620.60.17-0.280.30.78-0.01-0.17-0.46-0.3
Total Current Liabilities
-0.12-0.420.630.92-0.02-0.040.090.680.02-0.160.89-0.03-0.17-0.24-0.58-0.490.670.25-0.30.560.860.12-0.19-0.3-0.3
Total Stockholder Equity
0.290.70.09-0.1-0.02-0.110.130.04-0.32-0.810.110.33-0.76-0.88-0.540.71-0.310.29-0.90.190.030.89-0.930.48-0.88
Other Liab
-0.26-0.150.340.14-0.04-0.11-0.35-0.35-0.160.2-0.040.15-0.27-0.09-0.25-0.06-0.150.520.07-0.4-0.05-0.180.07-0.31-0.05
Property Plant And Equipment Net
0.29-0.080.180.050.090.13-0.35-0.010.14-0.410.11-0.10.37-0.19-0.04-0.09-0.32-0.36-0.220.02-0.050.35-0.210.52-0.2
Current Deferred Revenue
0.22-0.030.290.390.680.04-0.35-0.010.2-0.340.58-0.2-0.11-0.1-0.14-0.170.560.32-0.150.840.660.28-0.07-0.03-0.11
Net Debt
-0.19-0.370.020.020.02-0.32-0.160.140.2-0.05-0.11-1.00.240.190.17-0.460.21-0.10.20.310.13-0.040.2-0.260.21
Retained Earnings
-0.47-0.45-0.33-0.01-0.16-0.810.2-0.41-0.34-0.05-0.160.030.560.820.45-0.40.27-0.310.81-0.33-0.27-0.990.82-0.490.8
Accounts Payable
-0.27-0.170.660.750.890.11-0.040.110.58-0.11-0.160.1-0.15-0.24-0.56-0.240.650.31-0.320.550.780.15-0.22-0.11-0.32
Cash
0.210.38-0.02-0.03-0.030.330.15-0.1-0.2-1.00.030.1-0.23-0.2-0.160.46-0.240.08-0.21-0.32-0.140.06-0.220.29-0.22
Non Current Assets Total
-0.05-0.34-0.25-0.19-0.17-0.76-0.270.37-0.110.240.56-0.15-0.230.840.73-0.370.1-0.60.8-0.13-0.29-0.640.80.080.82
Non Currrent Assets Other
-0.23-0.3-0.38-0.24-0.24-0.88-0.09-0.19-0.10.190.82-0.24-0.20.840.81-0.330.29-0.410.98-0.15-0.28-0.870.98-0.210.99
Other Assets
0.240.12-0.61-0.65-0.58-0.54-0.25-0.04-0.140.170.45-0.56-0.160.730.810.09-0.07-0.420.8-0.14-0.59-0.50.760.130.83
Cash And Short Term Investments
0.280.98-0.32-0.62-0.490.71-0.06-0.09-0.17-0.46-0.4-0.240.46-0.37-0.330.09-0.370.07-0.320.0-0.430.49-0.40.66-0.32
Net Receivables
-0.44-0.240.150.60.67-0.31-0.15-0.320.560.210.270.65-0.240.10.29-0.07-0.370.030.180.610.61-0.290.27-0.380.21
Common Stock Total Equity
0.050.080.460.170.250.290.52-0.360.32-0.1-0.310.310.08-0.6-0.41-0.420.070.03-0.360.250.30.33-0.34-0.23-0.42
Non Current Liabilities Total
-0.21-0.32-0.35-0.28-0.3-0.90.07-0.22-0.150.20.81-0.32-0.210.80.980.8-0.320.18-0.36-0.24-0.32-0.870.99-0.220.99
Inventory
0.10.150.050.30.560.19-0.40.020.840.31-0.330.55-0.32-0.13-0.15-0.140.00.610.25-0.240.420.31-0.180.01-0.19
Other Current Assets
-0.26-0.340.710.780.860.03-0.05-0.050.660.13-0.270.78-0.14-0.29-0.28-0.59-0.430.610.3-0.320.420.22-0.22-0.24-0.31
Other Stockholder Equity
0.430.530.28-0.010.120.89-0.180.350.28-0.04-0.990.150.06-0.64-0.87-0.50.49-0.290.33-0.870.310.22-0.880.49-0.85
Total Liab
-0.23-0.38-0.28-0.17-0.19-0.930.07-0.21-0.070.20.82-0.22-0.220.80.980.76-0.40.27-0.340.99-0.18-0.22-0.88-0.260.99
Property Plant And Equipment Gross
0.250.69-0.14-0.46-0.30.48-0.310.52-0.03-0.26-0.49-0.110.290.08-0.210.130.66-0.38-0.23-0.220.01-0.240.49-0.26-0.19
Preferred Stock Total Equity
-0.18-0.3-0.39-0.3-0.3-0.88-0.05-0.2-0.110.210.8-0.32-0.220.820.990.83-0.320.21-0.420.99-0.19-0.31-0.850.99-0.19
Click cells to compare fundamentals

NeuroMetrix Account Relationship Matchups

High Positive Relationship

Preferred Stock Total Equity
+ 0.99
Non Currrent Assets Other
Total Liab
+ 0.99
Non Current Liabilities Total
Preferred Stock Total Equity
+ 0.99
Non Current Liabilities Total
Preferred Stock Total Equity
+ 0.99
Total Liab
Cash And Short Term Investments
+ 0.98
Total Assets
Non Current Liabilities Total
+ 0.98
Non Currrent Assets Other

High Negative Relationship

Cash
- 1.0
Net Debt
Other Stockholder Equity
- 0.99
Retained Earnings
Total Liab
- 0.93
Total Stockholder Equity
Non Current Liabilities Total
- 0.9
Total Stockholder Equity
Total Liab
- 0.88
Other Stockholder Equity
Preferred Stock Total Equity
- 0.88
Total Stockholder Equity

NeuroMetrix fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding121.0K3.8M2.6M891.3K1.0M1.1M
Total Assets6.9M8.0M24.9M24.7M21.4M17.5M
Other Current Liab2.1M1.5M515.9K309.9K586.7K557.3K
Total Current Liabilities3.4M2.3M1.4M1.1M1.2M1.2M
Total Stockholder Equity2.5M5.2M23.2M23.4M20.1M14.4M
Property Plant And Equipment Net1.4M876.2K673.9K536.2K543.6K599.7K
Net Debt(2.2M)(4.8M)(22.3M)(3.9M)(1.5M)(1.6M)
Retained Earnings(194.8M)(196.9M)(199.2M)(203.6M)(210.1M)(220.6M)
Accounts Payable725.7K142.3K284.0K368.1K215.5K204.7K
Cash3.1M5.2M22.6M4.3M1.7M1.6M
Non Current Assets Total1.5M904.7K700.3K562.6K570.0K541.5K
Non Currrent Assets Other74.9K29.7K28.5K26.4K30.4K31.9K
Other Assets30.3K29.7K721.2K700.3K630.3K600.4K
Cash And Short Term Investments3.1M5.2M22.6M21.2M18.0M12.0M
Net Receivables488.0K334.3K310.8K646.8K518.8K492.9K
Common Stock Total Equity271.0738.0140.0379.0341.1669.34
Liabilities And Stockholders Equity6.9M8.0M24.9M24.7M21.4M17.5M
Non Current Liabilities Total916.7K461.4K306.7K207.5K92.5K87.9K
Inventory1.2M1.1M706.6K1.6M1.6M1.6M
Other Current Assets2.3M478.1K598.4K645.5K779.0K1.5M
Other Stockholder Equity197.3M202.1M222.4M226.9M230.0M241.5M
Total Liab4.4M2.7M1.7M1.3M1.3M1.3M
Property Plant And Equipment Gross1.4M183.5K2.0M1.2M1.3M926.1K
Total Current Assets5.4M7.1M24.2M24.1M20.9M15.7M
Accumulated Other Comprehensive Income(1.1M)(1.2M)(1.2M)0.0240.2K252.2K
Common Stock140.0379.0668.0778.0152.0144.4
Property Plant Equipment2.4M273.4K183.5K673.9K606.5K621.0K
Retained Earnings Total Equity(191.3M)(191.0M)(194.8M)(196.9M)(177.2M)(186.1M)
Net Tangible Assets6.1M2.5M5.2M23.2M26.7M28.0M
Capital Surpluse196.4M197.1M197.3M202.1M232.4M201.3M
Net Invested Capital2.5M5.2M23.2M23.4M20.1M13.4M
Net Working Capital2.0M4.8M22.8M23.0M19.6M12.9M
Capital Stock141.0380.0669.0779.0153.0145.35

Pair Trading with NeuroMetrix

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeuroMetrix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroMetrix will appreciate offsetting losses from the drop in the long position's value.

Moving against NeuroMetrix Stock

  0.31LH LaboratoryPairCorr
The ability to find closely correlated positions to NeuroMetrix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeuroMetrix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeuroMetrix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeuroMetrix to buy it.
The correlation of NeuroMetrix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuroMetrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuroMetrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeuroMetrix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:
How To Invest In NeuroMetrix
Details
Is NeuroMetrix Stock a good investment?
Details
What is NeuroMetrix's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.51)
Revenue Per Share
2.157
Quarterly Revenue Growth
(0.51)
Return On Assets
(0.28)
Return On Equity
(0.43)
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY